Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
RIGL —
RIGEL PHARMACEUTICALS INC
CUSIP: 766559702 · Held by 2 superinvestors · Combined value: $33,455,712
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Jim Simons | 0.0% | $23,085,755 | 539,009 | ADD | +64,800 |
| 2 | Ken Griffin | 0.0% | $10,369,957 | 242,119 | ADD | +110,355 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +64,800 | +13.7% |
| Ken Griffin | ADD | +110,355 | +83.8% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +237,763 | +100.6% |
| Ken Griffin | ADD | +117,364 | +815.0% |
Who Owns RIGL? Superinvestor Holdings
RIGEL PHARMACEUTICALS INC is held by 2 tracked superinvestors, with a combined position value of $33 million . The largest positions are held by Jim Simons (0.0% of portfolio), Ken Griffin (0.0% of portfolio).
In the most recent quarter, 2 superinvestors added or initiated positions.